Hyperactivity-Mental Focus NDC 55714-4852

NDC codes

FDA NDC Directory

Product NDC (as listed)55714-4852Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55714-4852Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55714-4852-1	55714485201	30 mL in 1 BOTTLE, GLASS (55714-4852-1)Marketed from Jul 3, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Hyperactivity-Mental Focus
Generic name (nonproprietary): adrenalinum, aconitum nap., arg. nit., arsenicum alb., baptisia, chamomilla, cypripedium, digitalis, gelsemium, humulus, ignatia, impatiens glandulifera flos, iodium, lachesis, lycopodium, nat. mur., nux vom., scutellaria lateriflora, staphysag., stramonium, theridion, echinacea, gingko, hypericum, passiflora
Active ingredients: Epinephrine — 20 [hp_X]/mLAconitum napellus — 20 [hp_X]/mLSilver nitrate — 20 [hp_X]/mLArsenic trioxide — 20 [hp_X]/mLBaptisia tinctoria root — 20 [hp_X]/mLMatricaria chamomilla — 20 [hp_X]/mLCypripedium parviflorum var. Pubescens root — 20 [hp_X]/mLDigitalis — 20 [hp_X]/mLGelsemium sempervirens root — 20 [hp_X]/mLHops — 20 [hp_X]/mLStrychnos ignatii seed — 20 [hp_X]/mLImpatiens glandulifera flower — 20 [hp_X]/mLIodine — 20 [hp_X]/mLLachesis muta venom — 20 [hp_X]/mLLycopodium clavatum spore — 20 [hp_X]/mLSodium chloride — 20 [hp_X]/mLStrychnos nux-vomica seed — 20 [hp_X]/mLScutellaria lateriflora whole — 20 [hp_X]/mLDelphinium staphisagria seed — 20 [hp_X]/mLDatura stramonium — 20 [hp_X]/mLTheridion curassavicum — 20 [hp_X]/mLEchinacea, Unspecified — 11 [hp_X]/mLGinkgo — 11 [hp_X]/mLHypericum perforatum — 11 [hp_X]/mLPassiflora incarnata flowering top — 11 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Newton Laboratories, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jul 3, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)Adrenergic beta-Agonists (Mechanism)Allergens (Chemical structure)Allergens (Chemical structure)Catecholamines (Chemical structure)Cell-mediated Immunity (Physiologic effect)Cell-mediated Immunity (Physiologic effect)Dietary Proteins (Chemical structure)Food Additives (Chemical structure)Increased Histamine Release (Physiologic effect)Increased Histamine Release (Physiologic effect)Increased IgG Production (Physiologic effect)Plant Proteins (Chemical structure)Plant Proteins (Chemical structure)Seed Storage Proteins (Chemical structure)
Identifiers: Product ID 55714-4852_fed060c8-4f42-d865-e053-6294a90a5008SPL ID fed060c8-4f42-d865-e053-6294a90a5008SPL set ID fed03a1c-0ea8-1f8e-e053-6394a90a04c0UNII YKH834O4BH, U0NQ8555JD, 95IT3W8JZE, S7V92P67HO, 5EF0HWI5WU, G0R4UBI2ZZ, 21Y9GZ1LZA, F1T8QT9U8B, 639KR60Q1Q, 01G73H6H83, 1NM3M2487K, AJU5O1A5ZV, 9679TC07X4, VSW71SS07I, C88X29Y479, 451W47IQ8X, 269XH13919, 7BP4DH5PDC, 00543AP1JV, G6W4F0V8Z3, 9Z8D3HEM8L, 4N9P6CC1DX, 19FUJ2C58T, XK4IUX8MNB, CLF5YFS11O
Pharmacologic class: Catecholamine; Non-Standardized Food Allergenic Extract; Non-Standardized Plant Allergenic Extract; alpha-Adrenergic Agonist; beta-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455714485201 followed by a unit qualifier and the quantity

Package 55714-4852-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 23, 2023.

Indications (excerpt from the label)

INDICATIONS & USAGE SECTION Formulated for associated symptoms such as lack of focus, anxiety, anger, impulsiveness, restlessness and sensitivity.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)